Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 564(1-3): 181-9, 2007 Jun 14.
Article in English | MEDLINE | ID: mdl-17462625

ABSTRACT

A murine lung fibrosis model has been induced by challenging male Swiss albino mice with a fibrotic dose of bleomycin (10 mg/kg body weight, s.c.) twice weekly for 6 weeks. The model has been characterized and confirmed biochemically, histologically and morphometrically. Keeping in mind that inflammation is the forerunner of lung fibrosis, we have investigated the possible anti-fibrotic effect of meloxicam; a selective COX-2 inhibitor, in this lung fibrosis paradigm. When administered ahead of bleomycin challenge, meloxicam significantly reduced the lung content of hydroxyproline; the backbone of collagen matrix. This was further confirmed by the lower collagen deposition as revealed by histochemical examination of lung sections. Meloxicam had also anti-oxidant effect as shown by increase in lung reduced glutathione (GSH) level and decreases in lung malonedialdehyde (MDA) content and myeloperoxidase (MPO) activity. Besides, meloxicam has shown an apparent angiostatic activity. Histologically, meloxicam lessened lung inflammation and fibrotic changes induced by bleomycin. Taken together, one could conclude that meloxicam has shown anti-fibrotic effect in the bleomycin lung fibrosis model. Apart from its well-known anti-inflammatory potential, this anti-fibrotic action of meloxicam resides most probably, at least partly, in its anti-oxidant and angiostatic effects.


Subject(s)
Antioxidants/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Pulmonary Fibrosis/drug therapy , Thiazines/pharmacology , Thiazoles/pharmacology , Animals , Bleomycin , Collagen/drug effects , Collagen/metabolism , Disease Models, Animal , Glutathione/drug effects , Glutathione/metabolism , Hydroxyproline/drug effects , Hydroxyproline/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Meloxicam , Mice , Neovascularization, Pathologic/drug therapy , Peroxidase/drug effects , Peroxidase/metabolism , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism
2.
Drug Chem Toxicol ; 26(2): 87-98, 2003 May.
Article in English | MEDLINE | ID: mdl-12816394

ABSTRACT

The antioxidant and pro-oxidant effects of thymoquinone (TQ), a natural main constituent of the volatile oil of Nigella saliva seeds, and a synthetic structurally-related tert-butylhydroquinone (TBHQ), were examined in vitro. Both TQ and TBHQ efficiently inhibited iron-dependent microsomal lipid peroxidation in a concentration-dependent manner with median inhibitory concentration (IC50) values of 16.8 and 14.9 microM, respectively. TBHQ was stronger than TQ as a scavenger of 2,2'-diphenyl-p-picrylhydrazyl radical (DPPH) (IC50 = 5 microM, 200 times more active than TQ) and as a scavenger of hydroxyl radical (OH*) with an IC50 of 4.6 microM (approximately 10 times more active than TQ). TQ was more active than TBHQ as a superoxide anion scavenger with IC50 of 3.35 microM compared to 18.1 microM for TBHQ. Only TBHQ significantly promoted DNA damage in the bleomycin-Fe(III) system. The results suggest that both TQ and TBHQ have strong antioxidant potentials through scavenging ability of different free radicals. Moreover, the data indicate that TQ is acting mainly as a potent superoxide anion scavenger.


Subject(s)
Benzoquinones/pharmacology , Free Radical Scavengers/pharmacology , Nigella sativa , Superoxides/metabolism , Animals , Antioxidants/chemistry , Antioxidants/pharmacology , Antioxidants/toxicity , Benzoquinones/chemistry , Benzoquinones/toxicity , Biphenyl Compounds , Bleomycin/toxicity , DNA Damage/drug effects , Free Radical Scavengers/chemistry , Free Radical Scavengers/toxicity , Hydroquinones/chemistry , Hydroquinones/pharmacology , Hydroquinones/toxicity , In Vitro Techniques , Lipid Peroxidation/drug effects , Male , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Oxidation-Reduction , Picrates/chemistry , Plant Oils , Rats , Rats, Wistar
3.
Pharmacol Res ; 47(6): 509-15, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12742004

ABSTRACT

Dibromoacetonitrile (DBAN) is known to be water disinfectant by-product. Its broad-spectrum toxicity in different test systems in vivo and in vitro has been reported. Oxidative damage induced by DBAN may be partially responsible for its toxicity. Herein, the ability of DBAN to induce oxidative stress in mouse testis and possible protective effect of an antioxidant tertiary butylhydroquinone (TBHQ) were addressed. Male albino mice were injected with a single dose of DBAN (50mg/kg i.p.), and killed after 3h of treatment. Control animals received 10ml/kg body weight i.p. of the vehicle DMSO. In both experiments, cauda epididymis were dissected and sperm count and motility were investigated. Also, testicular activity of lactic dehydrogenase-x (LDH-x) isozyme and histopathological changes were examined. Furthermore, testicular content of malonyldialdehyde (MDA) and reduced glutathione (GSH) were determined. A single i.p. dose of DBAN caused decrease in sperm count and motility to approximately 88 and 84%, respectively, compared with control animals. A 46% decrease in testicular activity of LDH-x, compared with control animals, was observed. A significant accumulation of MDA in DBAN-treated animals was increased to 99% while testicular content of GSH was decreased by 56% compared to control animals. Compared to DBAN-treated animals, treatment with TBHQ (100mg/kg p.o.) prior exposure to DBAN showed a remarkable degree of protection as indicated by enhancement of sperm count and motility, testicular activity of LDH-x, and GSH. Accumulation of testicular content of MDA significantly decreased following TBHQ treatment compared to DBAN-treated animals. In conclusion, results presented here indicate that DBAN is capable to induce oxidative stress in mouse testis. TBHQ may play a protective role against DBAN-induced testicular cellular damage.


Subject(s)
Acetonitriles/antagonists & inhibitors , Acetonitriles/toxicity , Hydroquinones/pharmacology , Testis/drug effects , Analysis of Variance , Animals , Glutathione/metabolism , Isoenzymes/metabolism , L-Lactate Dehydrogenase/metabolism , Male , Malondialdehyde/metabolism , Mice , Oxidative Stress/drug effects , Sperm Count , Sperm Motility , Testis/metabolism , Testis/pathology
4.
Pharmacol Res ; 47(4): 349-54, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12644393

ABSTRACT

The present study was designed to investigate the possible modulator effect of melatonin on uterine estrogen and progesterone receptors in rats as well as the uterine response to oxytocin. Non-pregnant rats were pretreated with melatonin in a dose of 0.8 mg kg(-1) per day for 15 consecutive days. Control animals received the vehicle. The uterus was dissected out and uterine contraction in one horne was recorded in vitro for each animal as a response to oxytocin (0.5 x 10(-11) to 2 x 10(-11)M). The other uterine horne was subjected to estrogen and progesterone receptors detection by immunohistochemical and image analysis techniques. The results reveal a significant reduction (59%) in the number of uterine estrogen receptors with concomitant increase in the progesterone receptors (53%) in melatonin-pretreated rats as compared to the control ones. In addition, our data show an inhibitory effect of melatonin on the uterine contraction as a response to oxytocin (0.5 x 10(-11), 1 x 10(-11), and 2 x 10(-11)M) amounting to 48, 77, and 59.5% reduction, respectively, in the amplitude of contraction as well as 62, 19.9, and 47% reduction in the area under the curve (AUC) of uterine contractions, respectively. The data, so far obtained, may indicate a possible relationship of melatonin-induced modulation of the number of estrogen and progesterone receptors and its inhibitory effect on uterine contraction. These findings merit further investigations on the possible beneficial role of melatonin in a plethora of hormone-dependent uterine disorders.


Subject(s)
Antioxidants/pharmacology , Melatonin/pharmacology , Oxytocin/pharmacology , Receptors, Estrogen/drug effects , Receptors, Progesterone/drug effects , Uterine Contraction/drug effects , Animals , Female , Rats , Rats, Wistar , Uterine Contraction/physiology
5.
Pharmacol Res ; 46(3): 287-93, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12220973

ABSTRACT

Dibromoacetonitrile (DBAN) is a disinfection by-product following chlorination of drinking water. Epidemiological studies indicate that it might present a potential hazard to human health. DBAN was previously found to induce oxidative stress in rat stomach as manifested by perturbation of some enzymatic and nonenzymatic antioxidant parameters. Therefore, we have investigated the oxidative stress possibly induced by DBAN in mouse stomach and possible protection by melatonin (MLT) as a free radical scavenger. In a dose-response study, mice were administered a single oral dose of DBAN (30, 60 and 120 mg kg(-1)) and were sacrificed after 1 h. DBAN significantly reduced glutathione (GSH) content that was somehow dose-related, and inhibited glutathione-S-transferase (GST) activity in gastric tissues. The highest dose of DBAN (120 mg kg(-1)) lowered GSH by 74% and induced a significant elevation of lipid peroxidation products, determined as thiobarbituric acid reactive substances (TBARS) by 69%. The same dose inhibited the gastric activities of GST, superoxide dismutase (SOD) and catalase (CAT) by 70, 57 and 23%, respectively. In a time-course study, mice were administered DBAN (60 mg kg(-1) p.o.) and sacrificed 0.5, 1, 3, 6, 12 and 24 h after treatment. GSH was dramatically depleted at 0.5, 1, 3 and 6 h (45, 38, 39 and 49% of control, respectively) and remained significantly low at 12 and 24 h. Also, DBAN caused an accumulation of TBARS in gastric tissues starting from 3 h and was maximum at 6 h (133% of the control). The enzymatic activities of GST and SOD were maximally inhibited by DBAN treatment at 0.5 h (32% for GST and 37% for SOD of the respective control). The activities of both enzymes returned to control values at 24 h. CAT activity was not affected by DBAN administration at all. Pretreatment of another group of mice with melatonin (10 mg kg(-1) per day p.o. 12 days) before administration of DBAN (60 mg kg(-1) p.o.) completely mitigated the aforementioned parameters. In conclusion, the present study indicates that DBAN induces a marked oxidative stress in mouse stomach as evidenced by GSH depletion, TBARS accumulation and GST, SOD and CAT inhibition. Melatonin could mitigate DBAN-induced oxidative stress in mouse stomach as it did almost normalize both the enzymatic and nonenzymatic antioxidant parameters.


Subject(s)
Acetonitriles/administration & dosage , Antioxidants/pharmacology , Melatonin/pharmacology , Oxidative Stress/drug effects , Stomach/drug effects , Acetonitriles/toxicity , Administration, Oral , Animals , Catalase/drug effects , Catalase/metabolism , Gastric Mucosa/metabolism , Glutathione/drug effects , Glutathione/metabolism , Glutathione Transferase/drug effects , Glutathione Transferase/metabolism , Male , Mice , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...